On this page
Typically prepared by a compounding pharmacy under the direction of a licensed healthcare professional — not an FDA-approved finished product in this form.
Overview
Product & regulatory status
Provayblue is FDA approved for acquired methemoglobinemia. General oral wellness or cognitive use is not that approved indication.
Redox action
Methylene blue promotes conversion of methemoglobin back to hemoglobin. The relevance of other proposed mechanisms to routine cognition remains uncertain. [1]
What the evidence shows
Established clinical role
Provayblue treats acquired methemoglobinemia, a disorder in which hemoglobin cannot carry oxygen normally. This clinical use concerns a specific pathological state; it is not evidence that healthy people gain energy from routine exposure. [1]
Small acute cognition experiment
A 2016 randomized study enrolled 26 healthy adults. Methylene blue changed task-related brain imaging and was associated with better memory retrieval on a laboratory task. Acute testing in a small sample cannot establish durable cognition or dementia prevention. [2]
What remains unknown
Long-term cognitive benefit and safety during repeated wellness use remain unresolved. Imaging changes do not establish improved daily function.
Safety
Serotonin syndrome
The label warns of serious or fatal serotonin syndrome with serotonergic medicines and opioids. Medication review is essential, including psychiatric medicines. [1]
G6PD deficiency
Methylene blue is contraindicated in G6PD deficiency because severe hemolysis can occur. It can also interfere with oxygen-saturation monitoring. [1]
Separate formulations
The approved sterile IV product and an oral research preparation differ. The trial does not establish equivalence for commercially sold drops. [2]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Is a laboratory or aquarium product suitable for human use?
A chemical name alone does not establish pharmaceutical purity or an appropriate human medicine.
Does the memory study establish a daily nootropic?
No. It tested a limited acute research question, not long-term use or meaningful daily cognitive outcomes.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Provayblue prescribing informationUS prescribing information · revised February 2024 · DailyMed updated May 2025
- Rodriguez et al.: methylene blue and brain imagingRadiology, 2016; randomized placebo-controlled study in 26 healthy adults, acute imaging and short-term-memory tasks.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.